Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.
San Francisco, California, United States Related Funds
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Bone Health Technologies | $2M | 05 May 2021 | San Francisco, California, United States | ||
Zenflow | $24M | 15 Apr 2021 | South San Francisco, California, United States | ||
Materna Medical | $10M | 09 Apr 2021 | Mountain View, California, United States | ||
| $23M | 08 Dec 2020 | Richmond, Virginia, United States | |||
Tivic Health | $8M | 23 Jul 2019 | California, United States | ||
Kuli Kuli | $5M | 01 Mar 2019 | Oakland, California, United States | ||
CreditEnable | $5M | 31 Jan 2019 | London, England, United Kingdom | ||
Alydia Health | $10M | 28 Aug 2018 | California, United States | ||
Mi Padrino | $1M | 05 Jul 2018 | Ann Arbor, Michigan, United States |
– Zenflow, Inc. is a South San Francisco, CA-based medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH).
– Company raised $24m in Series B financing round.
– The round was led by Invus Opportunities with participation from F-Prime Capital, Medical Technology Venture Partners, Golden Seeds, Astia Angels, CloudStone Capital, SV Tech Ventures, and others.
– The new investment will be used to further develop the company’s Spring® System, a minimally invasive treatment option for patients who suffer debilitating symptoms due to enlarged prostate.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
